Tyra Biosciences, Inc. (TYRA)

NASDAQ: TYRA · IEX Real-Time Price · USD
12.46 0.24 (1.96%)
Jan 14, 2022 4:00 PM EST - Market closed
Market Cap514.17M
Revenue (ttm)n/a
Net Income (ttm)-13.64M
Shares Out41.27M
EPS (ttm)-5.26
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume96,007
Open11.96
Previous Close12.22
Day's Range11.80 - 12.54
52-Week Range11.06 - 31.36
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About TYRA

Tyra Biosciences is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Despite the therapeutic benefit that targeted oncology treatments have created for some patients, the response rate and duration of efficacy is often limited by acquired drug resistance and other shortcomings of existing therapies. We are using our proprietary SNÅP platform in order to generate next-generation product candidates that are specifically designed to address acqui...

IndustryBiotechnology
IPO DateSep 15, 2021
CEOTodd Harris, Ph.D.
Employees16
Stock ExchangeNASDAQ
Ticker SymbolTYRA
Full Company Profile

Financial Performance

Financial Statements

News

Tyra Biosciences to Present at the 2021 Jefferies London Healthcare Conference

CARLSBAD, Calif., Nov. 10, 2021 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve...

2 months ago - PRNewsWire

Tyra Biosciences Reports Third Quarter 2021 Financial Results and Highlights

CARLSBAD, Calif., Nov. 3, 2021 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve ...

2 months ago - PRNewsWire